XIT Corp formerly GSR III Acquisition Corp is a United States-based company. The Company is a wholly owned subsidiary of Terra Innovatum Global N.V. The Company is not engaged in any business activities. The Company has no revenue.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
20/08/26	US$5.770	-6.94%	347,457
19/08/26	US$6.200	+5.80%	244,545
18/08/26	US$5.860	-2.17%	142,577
17/08/26	US$5.990	-1.72%	182,794
14/08/26	US$6.095	-0.73%	129,055

Delayed Quote Nasdaq

More quotes

Market Closed - Nasdaq 21:00:00 20/08/2026 BST			5-day change	1st Jan Change
5.770 ^USD	-6.94%		-6.03%	-62.82%

11-17	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/10/25	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT

Market Cap	453M 388M 362M 332M 624M 43.32B 636M 4.29B 1.67B 21.71B 1.7B 1.66B 71.88B	P/E 2025 *	-	P/E 2026 *	-
Enterprise Value	453M 388M 362M 332M 624M 43.32B 636M 4.29B 1.67B 21.71B 1.7B 1.66B 71.88B	EV / Sales 2025 *	-	EV / Sales 2026 *	-
Free-Float	16.3%	Yield 2025 *	-	Yield 2026 *	-

11-17	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/10/25	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT
09/10/25	Terra Innovatum to begin trading on Nasdaq under the symbol "NKLR"	RE
08/10/25	GSR III Acquisition Corp.(NasdaqGM:GSRT) dropped from NASDAQ Composite Index	CI
08/10/25	Terra Innovatum s.r.l. completed the acquisition of GSR III Acquisition Corp. from GSR III Sponsor LLC and others in a reverse merger transaction.	CI
07/10/25	GSR III Acquisition Shareholders Approve Merger With Terra	MT
30/09/25	Terra Innovatum Announces Strategic Alliance with Defense Engineering Center, RAIT 88, to Accelerate Global Commercialization of SOLO?? Micro-Modular Nuclear Reactors	CI
29/09/25	Ameresco Signs MOU With GSR III, Terra Innovatum to Deploy Reactor Units	MT
29/09/25	Terra Innovatum signs MoU with Ameresco	RE
29/09/25	Terra Innovatum Partners with Ameresco to Jointly Pursue Public-Private Commercial Opportunities in the U.S. and Global Markets to Deploy SOLO Micro-Modular Reactor	CI
25/09/25	GSR III Acquisition, Terra Innovatum Secure $37.5 Million Equity Financing for Business Combination	MT
23/09/25	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
22/09/25	GSR III Acquisition Corp. announced that it expects to receive $31.84 million in funding	CI

23/09/25	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
12/08/25	Benchmark Initiates GSR III Acquisition at Buy With $19 Price Target	MT

GSR IIIPAR Share Price

Stocks

GSRT

KYG4R1031072

Investment Holding Companies

Valuation: GSR IIIPAR

Chart: GSR IIIPAR

Latest news : GSR IIIPAR

Analysts' recommendations: GSR IIIPAR

Press Releases: GSR IIIPAR

Quotes and Performance

Course Extremes

Latest insider transactions

Shell Companies

Financials

Company Profile

Quotes

30/09/25	Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders	AQ
22/09/25	Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO™ Reactor	AQ
16/09/25	Terra Innovatum Signs Supplier MOU with Conuar for Key SOLO Micro-Modular Reactor Components	AQ
15/09/25	Terra Innovatum and GSR III Acquisition Corp. Announce Effectiveness of S-4 and Set Extraordinary General Meeting Date to Approve Business Combination	AQ
09/09/25	TerraInnovatum Partners with ATB Riva Calzoni for Manufacturing of SOLO Micro-Modular Nuclear Reactor	AQ

1 year	5.6	15.62
3 years	5.6	15.62
5 years	5.6	15.62
10 years	5.6	15.62

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/10/25	Massimo Morichi	Conversion	See remarks; Director	360	4.4776%
16/10/25	Giordano Morichi	Conversion	See remarks	320	3.9801%
16/10/25	Guillaume Moyen	Conversion	Chief Financial Officer; Director	20	0.2488%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GSR IIIPAR	-6.94%	-6.03%	-44.36%	-	453M
CHURCHILL CAPITAL CORP XI	-3.63%	-13.09%	-	-	813M
CENTIEL AG	+6.40%	-1.69%	+310.59%	-70.17%	668M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.20%	+0.10%	-	-	645M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.19%	+0.68%	-	-	602M
CHURCHILL CAPITAL CORP XII	+0.84%	+0.84%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.29%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+1.04%	+0.61%	-	-	569M
CHURCHILL CAPITAL CORP XIII	+0.10%	-0.85%	-	-	507M
Average	-0.20%	-2.60%	+133.11%	-70.17%	605.02M
Weighted average by Cap.	-0.08%	-2.98%	+167.24%	-70.17%

1 day	-6.94%
Current month	-62.82%
Current year	-62.82%

	2025 *	2026 *
Net sales	-	-
Net income	-	-
Net Debt	-	-